The Molecular Bases of Phenylketonuria (PKU) in New South Wales, Australia: Mutation Profile and Correlation with Tetrahydrobiopterin (BH4) Responsiveness.

[1]  J. Reichardt,et al.  In vitro read-through of phenylalanine hydroxylase (PAH) nonsense mutations using aminoglycosides: a potential therapy for phenylketonuria , 2013, Journal of Inherited Metabolic Disease.

[2]  John J. Mitchell,et al.  Phenylalanine hydroxylase deficiency , 2011, Genetics in Medicine.

[3]  N. Blau,et al.  Molecular genetics and impact of residual in vitro phenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population. , 2011, Molecular genetics and metabolism.

[4]  V. Belakhov,et al.  Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations. , 2010, Bioorganic & medicinal chemistry.

[5]  Carol J. Saunders,et al.  Allele drop-out in the MECP2 gene due to G-quadruplex and i-motif sequences when using polymerase chain reaction-based diagnosis for Rett syndrome. , 2010, Genetic testing and molecular biomarkers.

[6]  R. Damoiseaux,et al.  Nonaminoglycoside compounds induce readthrough of nonsense mutations , 2009, The Journal of experimental medicine.

[7]  Niels Morling,et al.  Estimating the probability of allelic drop-out of STR alleles in forensic genetics. , 2009, Forensic science international. Genetics.

[8]  N. Blau,et al.  Genotype-predicted tetrahydrobiopterin (BH4)-responsiveness and molecular genetics in Croatian patients with phenylalanine hydroxylase (PAH) deficiency. , 2009, Molecular genetics and metabolism.

[9]  D. Bercovich,et al.  Genotype–phenotype correlations analysis of mutations in the phenylalanine hydroxylase (PAH) gene , 2008, Journal of Human Genetics.

[10]  Stephanie Cajigal.  FDA Approves Drug for Phenylketonuria , 2008 .

[11]  R. Stevens,et al.  Mutations in the regulatory domain of phenylalanine hydroxylase and response to tetrahydrobiopterin. , 2007, Genetic testing.

[12]  N. Blau,et al.  Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria. , 2007, The Journal of pediatrics.

[13]  Meenal Patel,et al.  PTC124 targets genetic disorders caused by nonsense mutations , 2007, Nature.

[14]  F. Güttler,et al.  Low proportion of whole exon deletions causing phenylketonuria in Denmark and Germany , 2007, Human mutation.

[15]  P. Mejstrik,et al.  Identification and characterization of large deletions in the phenylalanine hydroxylase (PAH) gene by MLPA: evidence for both homologous and non-homologous mechanisms of rearrangement. , 2006, Molecular genetics and metabolism.

[16]  A. Boneh,et al.  Three‐year audit of the hyperphenylalaninaemia/phenylketonuria spectrum in Victoria , 2006, Journal of paediatrics and child health.

[17]  Jongsun Jung,et al.  Structural and functional analyses of mutations of the human phenylalanine hydroxylase gene. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[18]  F. Chiarotti,et al.  The spectrum of phenylalanine variations under tetrahydrobiopterin load in subjects affected by phenylalanine hydroxylase deficiency , 2006, Journal of Inherited Metabolic Disease.

[19]  John J. Mitchell,et al.  Tetrahydrobiopterin-responsive phenylketonuria: the New South Wales experience. , 2005, Molecular genetics and metabolism.

[20]  N. Blau,et al.  Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria. , 2005, Molecular genetics and metabolism.

[21]  Dong Hwan Lee,et al.  The molecular basis of phenylketonuria in Koreans , 2004, Journal of Human Genetics.

[22]  Y. Chien,et al.  Mutation spectrum in Taiwanese patients with phenylalanine hydroxylase deficiency and a founder effect for the R241C mutation , 2004, Human mutation.

[23]  J. Zschocke.  Phenylketonuria mutations in Europe , 2003, Human mutation.

[24]  C. Aulehla‐Scholz,et al.  Mutational spectrum in German patients with phenylalanine hydroxylase deficiency , 2003, Human mutation.

[25]  S. Giannattasio,et al.  The molecular basis of phenylketonuria in Latvia , 2003, Human mutation.

[26]  Lynne Prevost,et al.  PAHdb 2003: What a locus‐specific knowledgebase can do , 2003, Human mutation.

[27]  V. Kučinskas,et al.  The molecular basis of phenylketonuria in Lithuania , 2003, Human mutation.

[28]  J. Seidel,et al.  DHPLC mutation analysis of phenylketonuria. , 2003, Molecular genetics and metabolism.

[29]  A. Roscher,et al.  Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. , 2002, The New England journal of medicine.

[30]  N. Blau,et al.  High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1,919 patients observed from 1988 to 2002. , 2002, Molecular genetics and metabolism.

[31]  G. Bertorelle,et al.  The mutation spectrum of hyperphenylalaninaemia in the Republic of Ireland: the population history of the Irish revisited , 2002, European Journal of Human Genetics.

[32]  A. Piazza,et al.  Genetic Heterogeneity in Five Italian Regions: Analysis of PAH Mutations and Minihaplotypes , 2001, Human Heredity.

[33]  E. Mayatepek,et al.  Tetrahydrobiopterin responsiveness in phenylketonuria differs between patients with the same genotype. , 2001, Molecular genetics and metabolism.

[34]  M. Zago,et al.  Mutations of the phenylalanine hydroxylase (PAH) gene in Brazilian patients with phenylketonuria , 2001, Human mutation.

[35]  C. Scriver.  The Metabolic and Molecular Bases of Inherited Disease , 2001 .

[36]  S. Antonarakis,et al.  Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .

[37]  X. Estivill,et al.  Mutational spectrum of phenylalanine hydroxylase deficiency in the population resident in Catalonia: genotype-phenotype correlation , 1999, Human Genetics.

[38]  S. Packman,et al.  Molecular Correlations in Phenylketonuria: Mutation Patterns and Corresponding Biochemical and Clinical Phenotypes in a Heterogeneous California Population , 1999, Pediatric Research.

[39]  P. Bénit,et al.  The mutant genotype is the main determinant of the metabolic phenotype in phenylalanine hydroxylase deficiency. , 1999, Molecular genetics and metabolism.

[40]  H. Sweeney,et al.  Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. , 1999, The Journal of clinical investigation.

[41]  R. Matalon,et al.  Relationship Among Genotype, Biochemical Phenotype, and Cognitive Performance in Females With Phenylalanine Hydroxylase Deficiency: Report From the Maternal Phenylketonuria Collaborative Study , 1999, Pediatrics.

[42]  P. Waters,et al.  Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations. , 1997, American journal of human genetics.

[43]  David Haussler,et al.  Improved splice site detection in Genie , 1997, RECOMB '97.

[44]  R. Matalon,et al.  Phenylalanine hydroxylase gene mutations in the United States: report from the Maternal PKU Collaborative Study. , 1996, American journal of human genetics.

[45]  D. Bedwell,et al.  Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations , 1996, Nature Medicine.

[46]  R. Cotton,et al.  Characterization of phenylalanine hydroxylase alleles in untreated phenylketonuria patients from Victoria, Australia: origin of alleles and haplotypes. , 1995, American journal of human genetics.

[47]  P. Guldberg,et al.  Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. , 1993, Genomics.

[48]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[49]  K. Robson,et al.  Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria , 1983, Nature.

[50]  C. Hollak,et al.  The 48-hour tetrahydrobiopterin loading test in patients with phenylketonuria: evaluation of protocol and influence of baseline phenylalanine concentration. , 2011, Molecular genetics and metabolism.

[51]  T. Flatmark,et al.  The G46S-hPAH mutant protein: a model to study the rescue of aggregation-prone PKU mutations by chaperones. , 2011, Molecular genetics and metabolism.

[52]  Hong Wang,et al.  [Mutations in exon 7 of the phenylalanine hydroxylase (PAH) gene in chinese patients with phenylketonuria]. , 2005, Yi chuan = Hereditas.

[53]  P. Waters,et al.  In vitro expression analysis of mutations in phenylalanine hydroxylase: Linking genotype to phenotype and structure to function , 1998, Human mutation.